Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

7.310 -0.010 (-0.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 427,562
Open 7.340
Bid (Size) 7.240 (1)
Ask (Size) 7.710 (1)
Prev. Close 7.320
Today's Range 7.225 - 7.365
52wk Range 6.715 - 21.88
Shares Outstanding 38,444,076
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AngioDynamics - Undervalued Gem In Med Tech: Analyst Eyes Stellar Growth With A 'Buy' Stance
H.C. Wainwright initiated coverage on AngioDynamics Inc (NASDAQ: ANGO), noting that the company is debt-free and significantly undervalued compared to peers in a growing market. 
Via Benzinga
Why AngioDynamics Stock Popped on Monday
AngioDynamics has fascinating technology, but few prospects for profits. 
Via The Motley Fool

Performance

YTD
-45.33%
-45.33%
1 Month
-8.97%
-8.97%
3 Month
-29.17%
-29.17%
6 Month
-26.01%
-26.01%
1 Year
-64.27%
-64.27%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga
AngioDynamics's Earnings: A Preview
Via Benzinga
Why Shares of AngioDynamics Rose Friday
Via The Motley Fool
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
From AngioDynamics, Inc.
Via Business Wire
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Performance Food Group, Stride, Progressive, H&R Block And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
From AngioDynamics, Inc.
Via Business Wire
Should Growth Investors Buy This Revolutionary Small-Cap Stock?
Via The Motley Fool
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
From AngioDynamics, Inc.
Via Business Wire
Why Are AngioDynamics Shares Trading Lower Today
Via Benzinga
Small Caps Lift Stock Futures As Traders Await Inflation Data: Analyst Says 'Now Is A Good Time' To Diversify Portfolios
Via Benzinga
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Investor Optimism Improves Ahead Of Inflation Data
Via Benzinga
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
From AngioDynamics, Inc.
Via Business Wire
Future Of Merit Medical Systems: Analyst Predictions On Revenue Growth And Operating Margin Improvement
Via Benzinga
AngioDynamics Divests Dialysis Portfolio And Biopsy Product Line To Merit Medical Systems For $100M
Via Benzinga
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
From AngioDynamics, Inc.
Via Business Wire
Top 5 Health Care Stocks That Are Preparing To Pump In Q2
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
Via Benzinga
AngioDynamics to Present at the Needham Virtual Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.